Aldeyra Therapeutics, Inc. (ALDX)
1.79
+0.01
(+0.56%)
USD |
NASDAQ |
Apr 13, 14:15
Aldeyra Therapeutics EPS Diluted (Quarterly) : -0.1074 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rhythm Pharmaceuticals, Inc. | -0.7302 |
| Pfizer Inc. | -0.2898 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| MediciNova, Inc. | -0.057 |
| Altimmune, Inc. | -0.2719 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.462M |
| Total Expenses (Quarterly) | 6.462M |
| Enterprise Value | 52.61M |
| Earnings Yield | -31.50% |
| Normalized Earnings Yield | -31.49 |